Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Market Trends
Antidepressant Demand Slows
Europe Dominates the Global Stress Management Market
Government Awareness Campaigns for Mental Health
Emerging Focus on Transcranial Magnetic Stimulation for Depression
Introduction of New Apps for Stress Management
Potential Growth of Off-Label Stress Reducers Such as ASMR
Market Dynamics
Factors Driving the Growth of the Market
Restraints
Chapter 4 Market Breakdown by Treatment Type
Drugs and Medications
Antidepressant Drugs
Atypical Antipsychotics
Beta-Blockers
Others (Benzodiazepines)
Therapies and Devices
Deep Brain Stimulation
Transcranial Magnetic Stimulation
Vagus Nerve Stimulation
Wearable Devices and Apps
ASMR (Autonomous Sensory Meridian Response)
Chapter 5 Market Breakdown by End User
Hospitals
Ambulatory Surgical Centers
Others
Chapter 6 Market Breakdown by Age Group
Children
Adults
Elderly
Chapter 7 Market Breakdown by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Brazil
Mexico
South Africa
Chapter 8 Patent Review/New Developments
Chapter 9 Analysis of Market Opportunities
Increasing Adoption of Wearables and Smart Devices for Stress Relief
Significant FDA Approvals for Neurological Therapies
Recent FDA Approvals
Key Suppliers and Manufacturers
Eli Lilly and Co.
Otsuka Holding Co., Ltd.
H. Lundbeck A/S
Johnson & Johnson Services Inc.
AstraZeneca PLC
Strategies
Product Launches and Approvals
Collaborations and Partnerships
Geographical Expansion
Chapter 10 Company Profiles
ABBOTT LABORATORIES INC.
ALKERMES PLC
ALLERGAN PLC
APPLE INC.
ASTRAZENECA PLC
AZUMIO INC.
BAUSCH HEALTH COMPANIES INC.
BEIJING PINS MEDICAL CO., LTD.
BIOCONTROL MEDICAL LTD.
BRAINSWAY LTD.
BRISTOL-MYERS SQUIBB CO.
CAEDEN INC.
DARTA SYSTEMS
DEVON MEDICAL PRODUCTS INC.
ELECTROMEDICAL PRODUCTS INTERNATIONAL INC.
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
FACEMETRICS LTD.
FISHER WALLACE LABORATORIES INC.
FITBIT INC.
GARMIN LTD.
GLAXOSMITHKLINE PLC
H. LUNDBECK A/S
HEADSPACE INC.
IBREVE LTD.
INTERAXON INC.
JOHNSON & JOHNSON SERVICES INC.
LIEF THERAPEUTICS
LIVANOVA PLC
LUPIN LTD.
MAG & MORE GMBH
MAGVENTURE INC.
MERCK & CO. INC.
MOOD TRACKER WEB MEDIA LLC
MYLAN N.V.
NEURONETICS INC.
NEUROSIGMA INC.
NEUVANA LLC
OTSUKA PHARMACEUTICAL CO., LTD.
PFIZER INC.
SAMSUNG ELECTRONICS CO., LTD.
SANVELLO HEALTH INC.
SPIRE INC.
TAKEDA PHARMACEUTICAL CO., LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
THYNC GLOBAL INC.
TINGLES INC.
WALDEN MEDICAL NEURO DIGITAL THERAPIES LLC



List of Figures


Summary Figure : Global Market for Stress Management Treatments, by Type, 2018-2024
Figure 1 : Breakdown of Mental Health-Related Insurance Claims, 2012-2017
Figure 2 : Share of Claims Tied to Generalized Anxiety Disorder Among Young People, 2014-2017
Figure 3 : Global Distribution of Diseases Causing Loss of Work Output, by Disease Type, 2018
Figure 4 : Global Incidence of Major Depressive Disorder, by Region, 2015-2017
Figure 5 : Behavioral Changes in Children: Depression and Anxiety, by Age Group, 2015
Figure 6 : Incidence of Anxiety Disorders in North America, 2013-2017
Figure 7 : Prevalence of Depressive Disorder in the U.S., 2013-2017
Figure 8 : Number of Clinical Studies Based on Trauma, by Type, 1988-2018
Figure 9 : Prevalence of Depressive Disorder in Canada, 2013-2017
Figure 10 : Regional European Shares of Populations with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 11 : Percentage of U.K.’s Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 12 : Percentage of Germany’s Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 13 : Percentage of France’s Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 14 : Percentage of Italy’s Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 15 : Percentage of Spain’s Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 16 : Percentage of Asia-Pacific’s Population with Depression, by Country, 2017
Figure 17 : Percentage of China’s Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
Figure 18 : Percentage of India’s Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
Figure 19 : Percentage of Japan’s Population with Behavioral Disorders, by Type of Disorder, 2017
Figure 20 : Percentage of Australia’s Population with Behavioral Disorders, by Type of Disorder, 2017
Figure 21 : Prevalence of Major Stress Disorders in Latin America, by Type of Disorder, 2015-2017
Figure 22 : Prevalence of Major Stress Disorders in Brazil, by Type of Disorder, 2015-2017
Figure 23 : Prevalence of Stress Disorders in Mexico, by Type of Disorder, 2015-2017
Figure 24 : Prevalence of Major Stress Disorders in South Africa, by Type of Disorder, 2015-2017

 

List of Tables


Summary Table : Global Market for Stress Management Treatments, by Type, Through 2024
Table 1 : Source of Stress Related to Specific Job Type
Table 2 : Most Common SSRIs and Their Side Effects
Table 3 : Global Market for Stress Management Treatments, by Type, Through 2024
Table 4 : Global Market for Stress Management Treatments, by Drug Type, Through 2024
Table 5 : Major Drug Classes Used in the Treatment of Stress-Associated Disorders
Table 6 : Global Market for Drugs and Medications Used for Stress Management, by Region, Through 2024
Table 7 : FDA Approved Antidepressants
Table 8 : Details of Atypical Antipsychotic Drugs
Table 9 : Global Market for Therapies and Devices Used in Stress Management, by Type, Through 2024
Table 10 : Global Market for Therapies and Devices Used in Stress Management, by Region, Through 2024
Table 11 : Wearable Devices and Apps Used for Stress Management
Table 12 : Global Market for Stress Management Treatments, by End User, Through 2024
Table 13 : Common Stress Management Services Offered in Hospitals
Table 14 : Global Market for Stress Management Treatments in Hospitals and Clinics, by Region, Through 2024
Table 15 : Global Market for Stress Management Treatments in Ambulatory Surgical Centers, by Region, Through 2024
Table 16 : Global Market for Stress Management Treatments in Other End Uses, by Region, Through 2024
Table 17 : Global Market for Stress Management Treatments, by Age Group, Through 2024
Table 18 : Global Market for Stress Management Treatments for Children, by Region, Through 2024
Table 19 : Major Causes of Stress Among Adults in the U.S.
Table 20 : Global Market for Stress Management Treatments for Adults, by Region, Through 2024
Table 21 : Global Market for Stress Management Treatments for the Elderly, by Region, Through 2024
Table 22 : Global Market for Stress Management Treatments, by Region, Through 2024
Table 23 : North American Market for Stress Management Treatments, by Type, Through 2024
Table 24 : North American Market for Stress Management Treatments, by End User, Through 2024
Table 25 : North American Market for Stress Management Treatments, by Age Group, Through 2024
Table 26 : North American Market for Stress Management Treatments, by Country, Through 2024
Table 27 : Canada’s Mental Health Resources, 2017
Table 28 : European Market for Stress Management Treatments, by Type, Through 2024
Table 29 : European Market for Stress Management Treatments, by End User, Through 2024
Table 30 : European Market for Stress Management Treatments, by Age Group, Through 2024
Table 31 : European Market for Stress Management Treatments, by Country, Through 2024
Table 32 : Germany’s Mental Health Resources, 2017
Table 33 : France’s Mental Health Resources, 2017
Table 34 : Italy’s Mental Health Resources, 2017
Table 35 : Spain’s Mental Health Resources, 2017
Table 36 : Asia-Pacific Market for Stress Management Treatments, by Type, Through 2024
Table 37 : Asia-Pacific Market for Stress Management Treatments, by End User, Through 2024
Table 38 : Asia-Pacific Market for Stress Management Treatments, by Age Group, Through 2024
Table 39 : Asia-Pacific Market for Stress Management Treatments, by Country, Through 2024
Table 40 : China’s Mental Health Resources, 2017
Table 41 : India’s Mental Health Resources, 2017
Table 42 : Rest of the World Market for Stress Management Treatments, by Type, Through 2024
Table 43 : Rest of the World Market for Stress Management Treatments, by End User, Through 2024
Table 44 : Rest of the World Market for Stress Management Treatments, by Age Group, Through 2024
Table 45 : Patents on Stress Management Treatments, by Category in Different Countries, January 2016-August 2019
Table 46 : Distribution of Major Patents on Stress Management Treatments, by Assignee, January 2016-December 2019
Table 47 : Total Patents Analyzed for Stress Management Treatments, January 2016-December 2019
Table 48 : Eli Lilly and Co.: Product Sales, by Country/Region, 2018
Table 49 : Otsuka Pharmaceutical’s Clinical Trials on Stress Management Treatments
Table 50 : H. Lundbeck: Product Sales, 2017 and 2018
Table 51 : Johnson & Johnson: Revenue Generated from Drugs Used in the Treatment of Depression, 2017 and 2018